Business Description
Divi's Laboratories Ltd
ISIN : INE361B01024
Share Class Description:
BOM:532488: Ordinary SharesCompare
Compare
Traded in other countries / regions
DIVISLAB.India IPO Date
2003-03-12Description
Divi's Laboratories Ltd is a specialty and generic drug manufacturing company. Most of the company's sales are generated in Europe, followed by North America, India, and Asia. The company has three distinct business segments: Generic APIs, Custom Synthesis, and Nutraceuticals. The company considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
Financial Strength
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1329 | |||||
Equity-to-Asset | 0.88 | |||||
Interest Coverage | 609 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 40.17 | |||||
Beneish M-Score | -1.91 | |||||
WACC vs ROIC |
Growth Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 4.6 | |||||
3-Year EBITDA Growth Rate | -4.5 | |||||
3-Year EPS without NRI Growth Rate | -7 | |||||
3-Year FCF Growth Rate | -37.1 | |||||
3-Year Book Growth Rate | 13.4 | |||||
Future 3-5Y Total Revenue Growth Rate | 7.9 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 72.02 | |||||
9-Day RSI | 67.64 | |||||
14-Day RSI | 67.14 | |||||
6-1 Month Momentum % | 11.48 | |||||
12-1 Month Momentum % | 21.9 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 7.57 | |||||
Quick Ratio | 5.08 | |||||
Cash Ratio | 3.12 | |||||
Days Inventory | 355.92 | |||||
Days Sales Outstanding | 90.05 | |||||
Days Payable | 92.33 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.65 | |||||
Dividend Payout Ratio | 0.5 | |||||
Forward Dividend Yield % | 0.65 | |||||
5-Year Yield-on-Cost % | 0.66 | |||||
Shareholder Yield % | 0.65 |
Profitability Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 60.12 | |||||
Operating Margin % | 23.29 | |||||
Net Margin % | 20.37 | |||||
FCF Margin % | 3.29 | |||||
ROE % | 12.29 | |||||
ROA % | 10.85 | |||||
ROIC % | 13.63 | |||||
ROC (Joel Greenblatt) % | 22.93 | |||||
ROCE % | 15.93 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 76.26 | |||||
PE Ratio without NRI | 76.26 | |||||
Shiller PE Ratio | 66.69 | |||||
Price-to-Owner-Earnings | 205.57 | |||||
PEG Ratio | 11.05 | |||||
PS Ratio | 15.51 | |||||
PB Ratio | 8.99 | |||||
Price-to-Tangible-Book | 8.99 | |||||
Price-to-Free-Cash-Flow | 472.93 | |||||
Price-to-Operating-Cash-Flow | 96.77 | |||||
EV-to-EBIT | 54.5 | |||||
EV-to-EBITDA | 46.4 | |||||
EV-to-Revenue | 15.05 | |||||
EV-to-FCF | 457.51 | |||||
Price-to-Projected-FCF | 5.55 | |||||
Price-to-DCF (Earnings Based) | 5.78 | |||||
Price-to-DCF (FCF Based) | 50.92 | |||||
Price-to-Peter-Lynch-Fair-Value | 10.91 | |||||
Price-to-Graham-Number | 5.52 | |||||
Price-to-Net-Current-Asset-Value | 15.69 | |||||
Price-to-Net-Cash | 58.44 | |||||
Earnings Yield (Greenblatt) % | 1.83 | |||||
FCF Yield % | 0.21 | |||||
Forward Rate of Return (Yacktman) % | 7.59 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Divi's Laboratories Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₹) | 78,450 | ||
EPS (TTM) (₹) | 60.27 | ||
Beta | 0.72 | ||
Volatility % | 26.59 | ||
14-Day RSI | 67.14 | ||
14-Day ATR (₹) | 102.756567 | ||
20-Day SMA (₹) | 4493.41 | ||
12-1 Month Momentum % | 21.9 | ||
52-Week Range (₹) | 3300 - 4644 | ||
Shares Outstanding (Mil) | 265.47 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Divi's Laboratories Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Divi's Laboratories Ltd Stock Events
Event | Date | Price(₹) | ||
---|---|---|---|---|
No Event Data |
Divi's Laboratories Ltd Frequently Asked Questions
What is Divi's Laboratories Ltd(BOM:532488)'s stock price today?
The current price of BOM:532488 is ₹4595.20. The 52 week high of BOM:532488 is ₹4644.00 and 52 week low is ₹3300.00.
When is next earnings date of Divi's Laboratories Ltd(BOM:532488)?
The next earnings date of Divi's Laboratories Ltd(BOM:532488) is 2024-08-30 Est..
Does Divi's Laboratories Ltd(BOM:532488) pay dividends? If so, how much?
The Dividend Yield %  of Divi's Laboratories Ltd(BOM:532488) is 0.65% (As of Today), Highest Dividend Payout Ratio of Divi's Laboratories Ltd(BOM:532488) was 0.64. The lowest was 0.18. And the median was 0.37. The  Forward Dividend Yield % of Divi's Laboratories Ltd(BOM:532488) is 0.65%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |